Skip to main content
. 2021 Jan 15;100(2):e24064. doi: 10.1097/MD.0000000000024064

Table 3.

Incidence of adverse events during treatment.

Adverse event HIFU alone (n = 30) CEUS+HIFU (n = 34) P
Sacrococcygeal pain 5/30 (16.7%) 4/34 (11.8%) .573
Skin burn 0/30 (0%) 0/34 (0%)
Pain in treatment zone 6/30 (20.0%) 8/34 (23.5%) .733
Groin pain 1/30 (3.3%) 0/34 (0%) .469
Sensation of rectal tenesmus 2/30 (6.7%) 1/34 (2.9%) .482
Leg pain 1/30 (3.3%) 0/34 (0%) .469

Data are presented as n/N (%). The following pain rating scale was used: 0 = painless; 1 to 2 = mild pain; 3 to 4 = moderate pain; 5 to 6 = severe pain; 7 to 8 = very severe pain; and 9 to 10 = unbearable pain. The pain score was <4 points in all patients.